Precigen Inc (NASDAQ:PGEN) has a beta value of 1.63 and has seen 2.41 million shares traded in the last trading session. The company, currently valued at $574.03M, closed the last trade at $1.96 per share which meant it lost -$0.02 on the day or -1.01% during that session. The PGEN stock price is -4.08% off its 52-week high price of $2.04 and 66.84% above the 52-week low of $0.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.55 million shares traded. The 3-month trading volume is 1.78 million shares.
The consensus among analysts is that Precigen Inc (PGEN) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.06.
Precigen Inc (NASDAQ:PGEN) trade information
Sporting -1.01% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PGEN stock price touched $1.96 or saw a rise of 6.67%. Year-to-date, Precigen Inc shares have moved 75.00%, while the 5-day performance has seen it change 15.29%. Over the past 30 days, the shares of Precigen Inc (NASDAQ:PGEN) have changed 73.45%. Short interest in the company has seen 19.04 million shares shorted with days to cover at 8.67.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 67.33% from current levels. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the current price level is -206.12% off the targeted high while a plunge would see the stock gain -206.12% from current levels.
Precigen Inc (PGEN) estimates and forecasts
The company’s shares have gained 75.00% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -35.67%.
5 analysts offering their estimates for the company have set an average revenue estimate of 1.3M for the current quarter. 3 have an estimated revenue figure of 733.33k for the next ending quarter. Year-ago sales stood 1.23M and 1.06M respectively for this quarter and the next, and analysts expect sales will grow by 5.86% for the current quarter and -35.67% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 36.94% over the past 5 years.
PGEN Dividends
Precigen Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Insiders own 9.93% of the company shares, while shares held by institutions stand at 66.43% with a share float percentage of 73.75%. Investors are also buoyed by the number of investors in a company, with Precigen Inc having a total of 175.0 institutions that hold shares in the company. The top two institutional holders are PATIENT CAPITAL MANAGEMENT, LLC with over 18.17 million shares worth more than $28.72 million. As of 2024-06-30, PATIENT CAPITAL MANAGEMENT, LLC held 7.2926% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 10.25 million shares as of 2024-06-30. The firm’s total holdings are worth over $16.19 million and represent 4.1116% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Trust for Advised Port-Patient Opportunity Trust and Vanguard Total Stock Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 4.92% shares in the company for having 14.4 shares of worth $28.22 million while later fund manager owns 5.45 shares of worth $10.69 million as of Sep 30, 2024 , which makes it owner of about 1.86% of company’s outstanding stock.
